about
technology
licensing
news
contact
about
technology
licensing
news
contact
News & Events
November 15, 2022
Ablexis and AlivaMab Discovery Services Announce Expansion of Antibody Drug Discovery and Engineering Capabilities
/ READ MORE
January 31, 2022
Ablexis and AlivaMab Discovery Services Announce Agreements with Almirall to Accelerate Antibody Drug Discovery and Development
/ READ MORE
May 4, 2021
Ablexis Announces Multi-Target License Agreement with Tanabe Research Laboratories U.S.A.
/ READ MORE
October 16, 2020
Ablexis Announces Further Expansion of Its Intellectual Property on AlivaMab® Mouse and Immunoglobulin Locus Engineering
/ READ MORE
April 22, 2020
Ablexis, AlivaMab Discovery Services, and Berkeley Lights Collaborate to Identify a Diverse Panel of Anti-SARS-CoV-2 Human Antibodies
/ READ MORE
September 17, 2019
AlivaMab Discovery Services Announces Multi-Target Agreement with Janssen
/ READ MORE
June 3, 2019
Ablexis Announces Multi-Target Licensing Agreement with Zai Lab (US)
/ READ MORE
January 17, 2019
Ablexis Announces Expansion of Non-Exclusive Perpetual License Agreement with Eli Lilly and Company
/ READ MORE
January 3, 2019
Ablexis Announces Licensing Agreement with Corvidia Therapeutics
/ READ MORE
December 6, 2018
Ablexis Announces Licensing Agreement with Allogene Therapeutics
/ READ MORE
November 13, 2018
Ablexis Announces Progress in Its Intellectual Property on AlivaMab Mouse and Immunoglobulin Locus Engineering
/ READ MORE
November 5, 2018
Ablexis Announces Antibody Discovered Using AlivaMab Mouse Platform Enters Clinical Development
/ READ MORE
October 23, 2018
Ablexis Announces Licensing Agreement with Voyager Therapeutics
/ READ MORE
October 9, 2018
Ablexis Announces Licensing Agreement with Memorial Sloan Kettering Cancer Center
/ READ MORE
June 21, 2018
Ablexis Targets Market Expansion Opportunities for AlivaMab Mouse Following Acquisition by Deerfield Management and the Founding of AlivaMab Discovery Services
/ READ MORE
Conferences
West Coast Antibody HubXChange
September 23, 2024. San Francisco, CA
Articles
Featured in Nature Biopharma Dealmakers
Ablexis and AlivaMab Discovery Services
Unparalleled success in antibody discovery and development
Download PDF